Company: KEQU
Filing Date: 2025-03-12
Form Type: 8-K
Source: 0000055529-25-000009
Chunk: 0

Company: KEWAUNEE SCIENTIFIC CORP /DE/
Filing Date: 2025-03-12
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events

On March 12, 2025, the Board of Directors of Kewaunee Scientific Corporation (the "Company") amended its existing share repurchase program initially approved on August 31, 2023, and in effect September 1, 2023. The Board of Directors authorized the repurchase of up to an additional 100,000 shares of the Company's common stock under the existing share repurchase program, as amended (the "Program"), which does not have a specified expiration date. The Program, as of the end of day March 12, 2025 and prior to this amendment, still had 11,176 shares authorized for repurchase which remain authorized for repurchase and are unaffected by this amendment.

The timing and amount of any repurchases under the Program will be determined by the Company's management at its discretion based upon its ongoing assessments of the capital needs of the business, the market price of the Company's common stock and general market conditions. Share repurchases under this program may be made through a variety of methods including open-market purchases, block trades, exchange transactions, or any combination thereof. The Program does not oblige the Company to acquire any amount of its common stock, and the Program may be suspended or discontinued at any time at the Company's discretion.

On March 12, 2025, the Company issued a press release regarding the amendment described above, a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K and incorporated herein by reference.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits

  Exhibit No.      Description                                                                  
         99.1      Press Release of Kewaunee Scientific Corporation dated March 12, 2025.       
 ────────────────────────────────────────────────────────────────────────────────────────────────
          104      Cover Page Interactive Data File (embedded within the Inline XBRL document)  

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  KEWAUNEE SCIENTIFIC CORPORATION                                 
  By                                   /s/ Donald T. Gardner III  
                                       Donald T. Gardner III      
                                       Vice President, Finance    
                                       Chief Financial Officer